Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Mier

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1980
Development and characterization of allospecific long-term human cytolytic T-cell linesC S Reiss, M E Hemler, V H Englehard, et al.
The New England Journal of Medicine|June 16, 1988
Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cellsM B Atkins, J W Mier, D R Parkinson, et al.
Cancer Research|December 1, 1986
Inhibitory effects of elevated temperature on human cytokine production and natural killer activityC A Dinarello, R A Dempsey, M Allegretta, et al.
Immunology|August 1, 1991
Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonistP Conti, R A Dempsey, M Reale, et al.
The Journal of Clinical Investigation|June 1, 1990
Melanotropin receptors demonstrated in situ in human melanomaJ B Tatro, M Atkins, J W Mier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancyM B Atkins, G Vachino, H J Tilg, et al.
Immunology Letters|March 1, 1992
Granulocyte-macrophage colony stimulating factor potentiates human polymorphonuclear leukocyte aggregation responses to formyl-methionyl-leucyl-phenylalanineP Conti, M Reale, R C Barbacane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Induction of circulating IL-1 receptor antagonist by IFN treatmentH Tilg, J W Mier, W Vogel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitroH Tilg, L Shapiro, E Vannier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1982
The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activityR A Dempsey, C A Dinarello, J W Mier, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1980
Development and characterization of allospecific long-term human cytolytic T-cell linesC S Reiss, M E Hemler, V H Englehard, et al.
The New England Journal of Medicine|June 16, 1988
Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cellsM B Atkins, J W Mier, D R Parkinson, et al.
Cancer Research|December 1, 1986
Inhibitory effects of elevated temperature on human cytokine production and natural killer activityC A Dinarello, R A Dempsey, M Allegretta, et al.
Immunology|August 1, 1991
Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonistP Conti, R A Dempsey, M Reale, et al.
The Journal of Clinical Investigation|June 1, 1990
Melanotropin receptors demonstrated in situ in human melanomaJ B Tatro, M Atkins, J W Mier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancyM B Atkins, G Vachino, H J Tilg, et al.
Immunology Letters|March 1, 1992
Granulocyte-macrophage colony stimulating factor potentiates human polymorphonuclear leukocyte aggregation responses to formyl-methionyl-leucyl-phenylalanineP Conti, M Reale, R C Barbacane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Induction of circulating IL-1 receptor antagonist by IFN treatmentH Tilg, J W Mier, W Vogel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitroH Tilg, L Shapiro, E Vannier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1982
The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activityR A Dempsey, C A Dinarello, J W Mier, et al.
Pageof 9